Screening For Breast Cancer Amongst High-Risk Population At A Tertiary Care Hospital from Rawalpindi

Maria Mir Jan; Syeda Qamar  Rifat Naqvi; Zaini  Azam; Shandana  Gul; Maham  Tariq; Said  Zaman

doi:10.51253/pafmj.v76iSUPPL-1.11743

Authors

Maria Mir Jan Department of Breast Surgery, Combined Military Hospital Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Syeda Qamar Rifat Naqvi Department of Breast Surgery, Combined Military Hospital Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Zaini Azam Department of Breast Surgery, Combined Military Hospital Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Shandana Gul Department of Breast Surgery, Combined Military Hospital Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Maham Tariq Department of Breast Surgery, Combined Military Hospital Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Said Zaman Department of Breast Surgery, Combined Military Hospital Rawalpindi/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76iSUPPL-1.11743

Keywords:

Breast Cancer, Mammography, Screening, Sonomammography

Abstract

Objective: To identify high-risk for breast cancer population amongst entitled females and to detect breast disease/cancer by screening tests (mammography or sonomammography) in the high-risk/symptomatic group.

Study Design: Cross-sectional study.

Place and Duration of Study: Breast Surgery Department, Combined Military Hospital Rawalpindi, Pakistan, from Sep 2022 to Feb 2023.

Methodology: In 3 phases, questionnaire based on the Gail model (translated to Urdu) were sent to entitled female Rawalpindi area and its periphery. A “Yes” response indicated high-risk/symptomatic females, who were then called to the department for screening. Bilateral (B/L) Sonomammography in women less than 40 years and B/L mammography for over 40 years females was done.

Results: Out of 2000 questionnaires sent, 1418(70.9%) responded. Nine hundred and twenty-two (65.0%) of these were below 40 years of age. Seventy-four high-risk cases underwent 41 sonomammographies and 33 mammograms. Twenty-four (32.0%) of results were unremarkable, 23(31.0%) benign breast lesions, 2 ductal carcinoma in-situ (DCIS) requiring excision. Fifteen (20.0%) newly diagnosed breast cancers were detected. Pre-diagnosed cases of 9(12.0%) breast cancers were also checked, including a BRCA1 patient. The predominant stage for new cancers was Stage-II (46.0%), while it was III (44.0%) for old cases. Total of 24 (32.0%) breast cancer cases from high-risk screened population accounted for 1.8% of the studied group.

Conclusion: The study emphasized the need for screening program in Pakistan, and indicated that more young females in spite of no risk factors developed breast cancer.

Downloads

Download data is not yet available.

References

1. Zaheer S, Shah N, Maqbool SA, Soomro NM. Estimates of past and future time trends in age-specific breast cancer incidence among women in Karachi, Pakistan: 2004–2025. BMC Public Health 2019; 19(2): 1-9.

https://doi.org/10.1186/s12889-019-7330-z

2. Khan NH, Duan SF, Wu DD, Ji XY. Better reporting and awareness campaigns needed for breast cancer in Pakistani women. Cancer Manag Res 2021; 2(1): 2125-2129.

http://doi.org/10.2147/CMAR.S270671

3. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA. Cancer mortality in the 50-69-year age group before and after screening. J Med Screen 2010; 17(3): 159-160.

https://doi.org/10.1258/jms.2010.010083

4. Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer Targets Ther 2019: 151-164.

http://dx.doi.org/10.2147/BCTT.S176070

5. Ginsburg O, Yip CH, Brooks A, Cabanes A, Caleffi M, Dunstan JA, et al. Breast cancer early detection: A phased approach to implementation. Cancer 2020; 126(1): 2379-2393.

https://doi.org/10.1002/cncr.32887

6. Mubarik S, Sharma R, Hussain SR, Iqbal M, Nawsherwan, Liu X. Breast cancer mortality trends and predictions to 2030 and its attributable risk factors in East and South Asian Countries. Front Nutr 2022; 9: 847920.

https://doi.org/10.3389/fnut.2022.847920

7. Fitzgerald RC, Antoniou AC, Fruk L, Rosenfeld N. The future of early cancer detection. Nat Med 2022; 28(4): 666-677.

https://doi.org/10.1038/s41591-022-01746-x

8. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012; 367(21): 1998-2005.

https://doi.org/10.1056/nejmoa1206809

9. Ginsburg O, Yip CH, Brooks A, Cabanes A, Caleffi M, Dunstan Yataco JA, et al. Breast cancer early detection: A phased approach to implementation. Cancer 2020; 126(1): 2379-2393. https://doi.org/10.1002/cncr.32887

10. Qaseem A, Lin JS, Mustafa RA, Horwitch CA, Wilt TJ. Clinical Guidelines Committee of the American College of Physicians. Screening for breast cancer in average-risk women: a guidance statement from the American College of Physicians. Ann Intern Med 2019; 170(8): 547-560.

https://doi.org/10.7326/m18-2147

11. Helvie MA, Bevers TB. Screening mammography for average-risk women: the controversy and NCCN's position.

J Natl Compr Canc Netw 2018; 16(11): 1398-1404.

https://doi.org/10.6004/jnccn.2018.7081

12. Narayan AK, Lee CI, Lehman CD. Screening for breast cancer. Med Clin 2020; 104(6): 1007-1021.

https://doi.org/10.1016/j.mcna.2020.08.003.

13. Klarenbach S, Sims-Jones N, Lewin G, Singh H, Thériault G, Tonelli M, et al. Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer. Can Med Assoc J 2018; 190(49): e1441-1451.

https://doi.org/10.1503/cmaj.180463

14. da Costa RA, Biller G, Uemura G, Ruiz CA, Curado MP. Breast cancer screening in developing countries. Clinics 2017; 72: 244-253. https://doi.org/10.6061/clinics/2017(04)09

15. Shieh Y, Eklund M, Madlensky L, Sawyer SD, Thompson CK, Stover Fiscalini A, et al. Athena Breast Health Network Investigators. Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial. J Nat Canc Inst 2017; 109(5): djw290.

https://doi.org/10.1093/jnci/djw290

16. Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, et al. Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020. Canc Commun 2021; 41(11): 1183-1194.

https://doi.org/10.1002/cac2.12207

17. Majeed AI, Ullah A, Jadoon M, Ahmad W, Riazuddin S. Screening, diagnosis and genetic study of breast cancer patients in Pakistan. Pak J Med Sci 2020; 36(2): 16.

https://doi.org/10.12669/pjms.36.2.1059

18. Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol 2022; 95(1130): 20211033.

https://doi.org/10.1259/bjr.20211033

19. Zaidi Z, Cherif MH. The worldwide female breast cancer incidence and survival, 2018. Pan Arab J Oncol 2019; 12(2).

https://doi.org/10.1158/1538-7445.AM2019-419